Intellectual Property Policy
In response to questions and comments related to Intellectual Property (IP) rights in IMI projects, the Innovative Medicines Initiative will provide guidance on the IMI IP rules and explore ways on how to handle IP related issues and pitfalls that participants may encounter during the preparation, negotiation and completion phases of the Grant Agreement and Project Agreement.
An IMI IP Guidance Note is being finalised as the result of constructive discussions among IMI stakeholders (industry, European Commission, member states and academia) gathered in the IMI IP Working Group. It will be published around the time of the launch of the 3rd Call for proposals and will be available on the IMI web page on IP.